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stain), iliac neointimal hyperplasia (I/M ratios) and Mac density (RAM-11 stain) were 
examined. Mats decreased significantly in groups treated with the combination of MGd 
and Asc, more than with Asc alone (Table). In vitro. cellular uptake of MGd (50wM/24h) 
by flow cytometry (fluorescence>650nm) showed median fluorescence values of 
33.47t0.93, 26.46+1.40 and 6.48iO.97 (mean&D) in human umbilical vein endothelial. 
coronary artery endothelial and smooth muscle cells respectively and 23.88iO.08 in 
Mats (THP-1 cells). Conclusion+ MGd uptake occurs in human vascular cells and 
Mats. Activation of MGd by Asc decreases Mats in rabbits, probably as a consequence 
of futile redox cycling and ROS generation. This approach offers pronwe for the treat- 
ment of vulnerable plaque. 
Groups 
Table. Study Results (meanrSEM) 
Contr MGd A.% MGd+Asc(- MGd+Asc(O YGd+Asc(+4 
01 4h) h) h) 
Aorhc 33.&E 37.9+11 39.6*9. 32.816.1 38.2i6.1 23.4e6.4 
plaque(%) .8 .9 7 
Iliac I/M ratios 2.2+0. 2.4kO.2 2.7iO.2 2.3r0.2 2.1zto.2 2.6t0.2 
1 
Iliac 30.3*1 31.7*1. 21.4-2. 13.0-1.1’ 12.6-1.1” 15.7-l .2’ 
Macs(%)# .3 2 1’ 
# % total intimal area, p<O.OOl by oneway ANOVA; ‘pcO.05 compared to control 
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1103-126 Endogenous Estrogens Influence Endothelial Function 
in Young Men 
Robert Lew Paul Komesaroff, Krishnankutty Sudhir, Baker Medlcal Research Institute, -t 
Melbourne, Australia 
Background: Estrogen is known to influence cardiovascular function In women. Males 
produce endogenous estrogen from testosterone via the enzyme aromatase. Previous 
studies have suggested a role for endogenous estrogens in cardiovascular function in 
men. We therefore examined the effects of reducing endogenous estrogen production by 
aromatase inhibition on vascular function and lipid levels in healthy young men. 
Methods: A double blind placebo controlled randomized design was used. Twenty 
healthy men, aged 18 to 32, were randomized to receive either the aroma&e inhibitor, 
anastrozole (lmg) or matching placebo. Sex hormone and lipid levels were measured. 
Endothelial function was assessed by flow mediated dilation (FMD) of the brachial artery 
in response to ischemic hyperemia of the forearm, and endothelium independent vasodi- 
lation was assessed as the effect of sublingual glyceryl trinitrate (GTN) on brachial artery 
diameter. Measurements were made at baseline and after 6 weeks of treatment. 
Results: There was one withdrawal in the treatment group, for unspecified reasons. 
Compared to baseline, a significant decrease in FMD was observed in subjects on anas- 
trozole. median 6.1 (5.2-13.4) to 3.5 (2.0-5.7) (p=O.O34), but there was no difference in 
the placebo group. No changes were observed in GTN-induced endothelial independent 
dilation following either anastrozole or placebo. There was a significant decrease in 
SStrOgSn concentrations with aromatase inhibition, mean 85.4 + 4.2pmoWL to 64.3 + 
&lpmol/L (p=O.O42). There were no significant changes in cholesterol, triglyceride, test- 
osterone or DHEA levels in either the anastrozole or placebo group. 
Conclusion: Selective suppression of endogenous estrogens by inhibition of aromatase 
In healthy young men results in impairment of flow mediated vasodilation. a response 
known to be mediated via local nitric oxide release. Our results suggest a role for endog- 
enous estrogens in endothelial function and vascular health in young males. 
1103-127 Role of Cytomegalovirus and Asymmetric 
Dimethylarginine in the Derangement of Nitric Oxide 
Synthase in Cardiac Allograft Recipients 
1103-129 Coronary Endothelial Dysfunction Is Associated With 
an Increased Risk of Cerebrovascular Events 
Binq Y. Wanq, 6111 Fearon, Ken Y. Lin. Shyam N. Panchal, Shao 2. Gao, Hannah A. Paul V. Taroonski, Prero 0 Bonett, Geralyn M. Pumper, Stuart T. Higano, David R. 
Valantine, John P. Cooke, Stanford University, Stanford, CA Holmes, Jr., Anw Lerman, Mayo Clinic, Rochester, MN 
Background We hypothesized that cytomegalovirus (CMV) induced increases in ADMA 
(asymmetric dimethylarginine, the endogenous inhibitor of NO synthesis) may contribute 
to the coronary endothelial dysfunction observed in cardiac allografl recipients. 
Methods and Results: Forty orthotopic heart transplant recipients without acute rejec- 
tion or infection episodes were studied. Heart transplant recipients manifested elevated 
ADMA levels (by HPLC) compared to non-transplant controls. Transplant patients wth 
CMV DNA positive leukocytes (by PCR) had higher ADMA plasma concentrations and 
more extensive coronary artery disease than transplant patients without leukccyie-asso- 
ciated CMV DNA. Four weeks after heart transplantation, five recipients , (male, mean 
age: 50.6 + 6.2 years) underwent coronary catheterization. Acetylcholine (ACH) and 
nitroglycerin (NTG) were infused into the LAD , and quantitative angiography was per- 
formed to assess vascular reactivity lmmedlately before and after Ach infusion, aortic 
and coronary sinus blood was drawn for calculation of basal and stimulated plasma NOx 
with Griess Assay. ACH caused paradoxical vasoconstriction (3.32 + 0.09 mm vs 2.83 + 
0.29 mm), whereas NTG induced significant dilation (2.61 + 0.17 mm vs 3.61 + 0.18 mm, 
P < O.Ol).The plasma NOx levels in the AIV were not Increased by ACH infusion in LAD 
Background: Stroke, due to atherothrombotic disease, represents a leading cause of 
disability and death in the western world. Endothelial dysfunction, which is considered a 
key factor in atherogenesis, is associated with an increased risk of cardiovascular 
events. However, the magnitude of the association between coronary endothelial dys- 
function (CED) and cerebrovascular events (CVE) is unknown. This study was performed 
to investigate the association between CED and CVE. 
Methods We studied 503 consecutive patients without obstructive coronary artery dis- 
ease (CAD) who underwent coronary endothelial function testing. Patients were stratified 
according to the presence (n=305) or absence (n=l98) of CED. Medical records were 
examined for the occurrence of CVE defined as ischemic or hemorrhagic stroke or tran- 
sient lschemic attack either preceding or following coronary endothellal function testing. 
Results A total of 25 cerebrovascular events were documented, 22 In patients with CED 
and 3 in patients without CED (p=O.OOE). Multivariable logistic regression, which included 
demographic characteristics and tradltional cerebrovascular disease-related risk factors, 
identified the presence of CED as the single strongest factor associated with CVE (odds 
ratio: 4.32; 95% Cl, 1.26-14.83). Kaplan-Meler analysts demonstrated a significantly 
(40.4 + 7.8 Urn vs 39.1 + 7.9 uM) indicating a severe impairment In NO synthesis. 
Conclusions: Synthesis of endothellal nitnc oxide is severely depressed in the coronary 
arteries of heart transplant patients. This abnormality may be secondary to high plasma 
levels of the circulating NOS inhibitor, ADMA. CMV infection exacerbates this abnormal- 
ity. 
1103-128 Coronary Endothelial Foot Print of Vasa Vasorum 
Perfusion Territories: Micro-Computed Tomography 
Analysis of Porcine Coronary Arteries With and Without 
Microembolization 
Mario Goessl, Nasser M. Malyar, Patricia E. Lund, Erik L. Ritman, Mayo Clinic, 
Rochester, MN 
Background As removal or ligation of vasa vasorum (VV) has been shown to cause ath- 
erosclerotic lesions, it seems likely that microembolization (ME) of coronary artery VV 
should also. This study starts to examine the question as to whether individual VV perfu- 
slon defects in the coronary artery wall due to ME occur in plaque-like distributions. 
Methods Non-radioactive microspheres (ps) 300 or 100&m in diameter were injected in 
3 porcine LADS each. After harvesting the heart, the LADS were injected with radiopaque 
Microfil? Up to 10 cm-long segments of the LADS were removed and scanned intact with 
micro-CT (20 pm cubic voxels). The spatial density (#/mn?) of VV was measured in 20 
pm-thick cross-sections (spaced at 0.8 mm intervals. distal to the&s-injection-site and in 
corresponding segments of 3 control LADS). These cross-sections were subdivided into 
2 epicardial (epi) and 2 myocardial (myo) quadrants. 
Results ME reduced VV densities (3.75r2.03 in controls vs 3.06i1.26 in 100 and 
2.5Ok1.44 in 300 pm ps; all P<O.OOl) and resulted in patchy distribution of longitudinal 
and circumferential W densities (Fig.). Epi VV densities were consistently higher than 
myo densities (4.49k3.27 vs 2.&X3*2.56 In controls; 3.57i2.22 vs 2.45e2.10 in 100 and 
3.21+2.76 vs 1.75e2.16 in 300 pm ps; all P<O.OOl). 
Conclusion Microembolization could be a proatherogenic factor by focally lmpainng cor- 
onary artery wall perfusion. Our data are also consistent with preferential plaque forma- 
tlon at the myocardial side of coronary arteries. 
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